The product, lonapegsomatropin, is a sustained-release formulation and could replace daily injections. The FDA recently approved the first once-weekly somatropin injection for pediatric patients 1 ...

COPENHAGEN, Denmark, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), today announced the U.S. commercial launch of SKYTROFA (lonapegsomatropin-tcgd), its once-weekly treatment ...

March 5, 2010 — The US Food and Drug Administration (FDA) has approved a prefilled somatropin (rDNA origin) injection pen (Norditropin FlexPro, Novo Nordisk, Inc) for the treatment of growth hormone ...

First of many planned label expansions supporting Vision 2030 goal to become the leading endocrinology rare disease company On track to initiate basket trial for ISS, SHOX deficiency, Turner syndrome, ...

Zomacton now approved for replacement of endogenous GH in adults with GH deficiency. Ferring announced that the Food and Drug Administration (FDA) has approved Zomacton (somatropin [rDNA origin]) ...

Feb. 24, 2005 — The U.S. Food and Drug Administration (FDA) approved in November and December 2004 revisions to safety labeling to advise healthcare professionals of the following changes: use of ...

Cangene has received FDA approval for Accretropin (recombinant somatropin injection), a human growth hormone (rhGH) for the treatment of children with growth failure due to an inadequate secretion of ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global somatropin market is estimated to be valued at US$ 5.02 billion in 2020 and is expected to exhibit a CAGR of 7.9% during the ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first once-weekly formulation of somatropin for children with growth hormone deficiency, ...

Every man desires to have a perfectly sculpted figure. When men see their six-pack abs, bulging biceps, and perfectly formed calves reflected in the mirror, they cannot help but feel better about ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global somatropin market is estimated to be valued at US$ 5.02 billion in 2020 and is expected to exhibit a CAGR of 7.9% during the ...